Search Results - "Anastopoulou, Garifallia G"

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors by Vilariño, Noelia, Bruna, Jordi, Kalofonou, Foteini, Anastopoulou, Garifallia G, Argyriou, Andreas A

“…Over the last decade, immune checkpoint inhibitors (ICIs) have revolutionized the treatment of several cancer types. ICIs work through the blockage of immune…”
Get full text

Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study by Argyriou, Andreas A., Bruna, Jordi, Kalofonou, Foteini, Velasco, Roser, Litsardopoulos, Pantelis, Alemany, Montse, Anastopoulou, Garifallia G., Kalofonos, Haralabos P.

“…Objective To define the incidence and risk factors for developing chemotherapy‐induced neuropathic pain (CINP). Methods Retrospective, file‐based analysis on…”
Get full text

Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials by Bruna, Jordi, Argyriou, Andreas A., Anastopoulou, Garifallia G., Alemany, Montse, Nadal, Ernest, Kalofonou, Foteini, Piulats, Josep M., Simó, Marta, Velasco, Roser, Kalofonos, Haralabos P.

“…Immune checkpoint inhibitors (ICIs) are associated with various neurological adverse events (NAEs). We herein explored the incidence and clinical phenotype of…”
Get full text

Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity by Argyriou, Andreas A., Bruna, Jordi, Anastopoulou, Garifallia G., Velasco, Roser, Litsardopoulos, Pantelis, Kalofonos, Haralabos P.

“…Aim To identify the risk factors of falls in a well-characterized cohort of cancer patients with chemotherapy-induced peripheral neurotoxicity (CIPN). Patients…”
Get full text

Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin‐induced peripheral neurotoxicity by Argyriou, Andreas A., Kalofonou, Foteini, Litsardopoulos, Pantelis, Anastopoulou, Garifallia G., Kalofonos, Haralabos P.

“…We investigated whether rechallenge with oxaliplatin (OXA) can worsen the pre‐existing oxaliplatin‐induced peripheral neurotoxicity (OXAIPN) in metastatic…”
Get full text

Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity by Argyriou, Andreas A., Kalofonou, Foteini, Litsardopoulos, Pantelis, Anastopoulou, Garifallia G., Psimaras, Dimitri, Bruna, Jordi, Kalofonos, Haralabos P.

“…We report the outcome of a pilot, open‐label study that tested the potential of lacosamide (200 mg/bi.d) as an effective and safe symptomatic treatment against…”
Get full text

Irreversible diffuse hypoxic-ischemic encephalopathy, secondary to type I Kounis syndrome by Anastogiannis, Haralabos, Litsardopoulos, Pantelis, Anastopoulou, Garifallia G, Petsas, Andreas, Tsigkas, Grigorios, Kounis, Nicholas G, Ravani, Ifigenia, Argyriou, Andreas A

“…We herein describe the unusual case of irreversible diffuse hypoxic-ischemic encephalopathy secondary to type I Kounis syndrome. The patient survived and…”
Get full text

Liability of the voltage‐gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin‐induced peripheral neurotoxicity by Argyriou, Andreas A., Antonacopoulou, Anna G., Alberti, Paola, Briani, Chiara, Bruna, Jordi, Velasco, Roser, Anastopoulou, Garifallia G., Park, Susanna B., Cavaletti, Guido, Kalofonos, Haralabos P.

“…Thus far, there are conflicting results on the causal role of K+ channels in the pathogenesis of acute oxaliplatin‐induced peripheral neurotoxicity (OXAIPN)…”
Get full text

Fatal, paraparetic acute motor axonal neuropathy, early complicating chemotherapy with nab-paclitaxel by Litsardopoulos, Pantelis, Bikas, Christos, Dimitropoulou, Dimitra, Lykoura, Chrysa, Anastopoulou, Garifallia G, Karanasios, Panagiotis, Makridou, Alexandra, Argyriou, Andreas A

“…So far, very few cases describing an interrelation between chemotherapy and Guillain–Barré syndrome have been published. We describe the first case of a…”
Get full text

Acute aseptic meningitis during isotretinoin treatment for nodular acne solely presenting with headache: case report and brief review of the literature by Chalimou, Ioanna, Krilis, Antonios, Anastopoulou, Garifallia G, Braun, Heike, Vikelis, Michael, Makridou, Alexandra, Makris, Nicolaos, Argyriou, Andreas A

“…Purpose/aim: We describe, in detail, the first case of isotretinoin-induced aseptic meningitis. A brief summary of the literature on drug-induced aseptic…”
Get full text

Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain by Argyriou, Andreas A, Anastopoulou, Garifallia G, Bruna, Jordi

Get full text

Irreversible diffuse hypoxic-ischemic encephalopathy, secondary to type I Kounis syndrome by Anastogiannis, Haralabos, Litsardopoulos, Pantelis, Anastopoulou, Garifallia G., Petsas, Andreas, Tsigkas, Grigorios, Kounis, Nicholas G., Ravani, Ifigenia, Argyriou, Andreas A.

“…We herein describe the unusual case of irreversible diffuse hypoxic-ischemic encephalopathy secondary to type I Kounis syndrome. The patient survived and…”
Get full text

Acute aseptic meningitis during isotretinoin treatment for nodular acne solely presenting with headache: case report and brief review of the literature by Chalimou, Ioanna, Krilis, Antonios, Anastopoulou, Garifallia G., Braun, Heike, Vikelis, Michael, Makridou, Alexandra, Makris, Nicolaos, Argyriou, Andreas A.

“…Purpose/aim: We describe, in detail, the first case of isotretinoin-induced aseptic meningitis. A brief summary of the literature on drug-induced aseptic…”
Get full text